Bristol Myers Squibb Adopts Anthropic’s Claude as Enterprise Intelligence Platform
Bristol Myers Squibb has entered a strategic agreement with Anthropic to implement Claude Enterprise as its shared intelligence platform across global operations, announced in a press release. The collaboration will extend across research, clinical development, manufacturing, commercial, and corporate functions, providing AI-driven reasoning and automation capabilities to more than 30,000 employees.
The deployment will use Claude Code to assist engineering and data science teams in standardizing AI and software development processes. This approach aims to unlock data and expertise within the company’s systems and improve efficiency in building and deploying digital solutions.
Bristol Myers Squibb plans to embed Claude agents into critical workflows such as research, drug development, manufacturing, and medical affairs. These agents will assist with tasks including analyzing proprietary scientific and clinical data, drafting trial documentation, supporting regulatory submissions, and streamlining manufacturing quality processes.
Through secure integrations with internal systems and knowledge repositories, Claude will connect institutional knowledge across departments under full enterprise governance and audit controls. This agreement builds on more than three years of AI investment at Bristol Myers Squibb, which has established the company as an early adopter of advanced AI capabilities in the biopharmaceutical sector.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Nov 20 Danaher and Microsoft build an agentic platform for lab instruments Nov 20 BlackLine brings OpenAI models to its finance operations platform with agent controls Nov 19 AWS Marketplace lets AI agents research and buy software, with optional pre-approved purchases Nov 19 Globant's AI Pods run rate more than doubles to $106.6 million as Q3 revenue dips 1% Nov 19 Anthropic offers credits of up to $2,000 per user to push its newer AI productsMore from Life Sciences
Nov 20 Danaher and Microsoft build an agentic platform for lab instruments Nov 19 Knit Health raises $35 million to roll out its healthcare world model Nov 19 Banner Health invests in Layer Health and moves its clinical registries onto its AI platform Nov 19 Half of Koreans who changed medication on AI advice had side effects, survey finds Nov 19 Isomorphic Labs and MSD team up to design cancer drugs with AILife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Cognizant puts more than 25,000 staff on Claude and launches managed services to run it
Anthropic launches Claude Meetings to join video calls and work on tasks live, plus Whiteboards and Sheets
Anthropic Expands Free Claude Credits to 20 Science Groups
Anthropic adds usage reports and pooled budgets to Claude Enterprise
Anthropic offers credits of up to $2,000 per user to push its newer AI products
Daily AI Brief: the AI news that matters, in your inbox.